Digital Medicine Market Report
The report on the Global Digital Medicine Market is segmented By Technology (Mobile Health, Telehealth, Wireless Health, EMR/EHR), Application (Diabetes, Asthma, Heart Disease, Obesity, COPD, Smoking, Drug Non-Adherence, Mental Health), and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Digital Medicine market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Digital Medicine Market is segmented By Technology (Mobile Health, Telehealth, Wireless Health, EMR/EHR), Application (Diabetes, Asthma, Heart Disease, Obesity, COPD, Smoking, Drug Non-Adherence, Mental Health), and Region....
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Digital Medicine Market is expected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over x% during the forecast period.
Digital Medicine is defined as a practice in which technology is used as a tool for measurement and intervention in human health services. It empowers the healthcare providers and patients with accessible tools to address a broad range of medical conditions through safe & effective methods. Digital medicine products can be used independently or along with pharmaceuticals, devices, and other products to improve patient health care.
Key players operating in the global Digital Medicine Market are-
The growth of the global digital medicine market is primarily driven by the increasing adoption of technologically advanced healthcare solutions coupled with growing digitalization across geographies.
Based on technology, the market has been segmented into mobile health, telehealth, wireless health, and EMR/EHR.
Geographically, the market in North America accounted for the largest market share in 2020.
Covid-19 outbreak impacted the growth of the Digital Medicine market positively. The COVID-19 pandemic has disrupted global economies and health care with extensive lockdowns and travel bans to prevent the spread of the virus. The fear of coronavirus infection and imposition of lockdown resulted in increased deployment of digital technology to address the healthcare problems.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
2Morrow, Inc. (The U.S), Ginger.io Inc. (The U.S), Akili Interactive Labs (The U.S), Livongo Health Inc (The U.S), AliveCor Inc. (The U.S), WellDoc Inc. (The U.S), MOCACARE (The U.S), Proteus Digital Health, Inc. (The U.S), Voluntis (France) and Omada Health, Inc (The U.S) are among the key players in the digital medicine market.
North America accounted for the largest share in the digital medicine market in 2020.
Asia-pacific is expected to grow at the fastest CAGR in the digital medicine market in the coming years.
The mobile health segment accounted for the largest share in the digital medicine market in 2020.
Increasing adoption of technologically advanced healthcare solutions coupled with growing digitalization across geographies, increasing number of people suffering from various diseases are the factors driving the growth of digital medicine market.
Digital medicine manufacturers, Digital medicine suppliers, Digital medicine distributors, Organizations, Government bodies are the target audience in the digital medicine market.